Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04MYO
|
|||
| Former ID |
DIB002133
|
|||
| Drug Name |
ABN-912
|
|||
| Synonyms |
Anti-CD46 mAb, Novartis; Anti-MCP1 monoclonal antibody, Novartis
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Discontinued in Phase 1 | [1] | |
| Company |
Novartis AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020409) | |||
| REF 2 | A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Aug;54(8):2387-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.